28 August 2017
Visiongain’s new report The Mass Spectrometry Market Forecast 2017-2027 – Revenue Prospects by Technology (Single, Ion Trap, Quadrupole, TOF, Hybrid, Triple Quadrupole, Q-TOF, FTMS), by Application (Academia, Biotech, Agriculture, CRO, Hospitals, Environmental, Materials) and Geography indicates that the global mass spectrometry market will see over $3.8bn in revenue in 2017.
The lead analyst of the report said:
“The mass spectrometry market is expected to experience considerable growth over the forecast period. The main drivers for the growth include the applications of the mass spectrometry in wide range of areas, technological advancements and adoption/acceptability of new technology by the government to address the healthcare challenges. The increasing disease burden and identification of antibacterial resistant strains is leading to therapeutical advancements, drug discovery and increase research and development activities to address this situation. The high-speed, accurate, sample analysis of simple to complex molecules/products by the mass spectrometry is leading to its increased demand in the areas such as clinical research, proteomic, metabolomics, and forensics including many others.”
The 183-page report contains 111 tables, charts and graphs that add visual analysis in order to explain developing trends within the mass spectrometry market. Visiongain provides revenue forecasts for the period 2017-2027 for the leading mass spectrometry submarkets, segmented by technology, with forecasts for single and hybrid mass spectrometry. The market is also segmented by product, and includes forecasts for Ion Trap, Quadrupole, TOF, Triple Quadrupole, Quadrupole-TOF and Fourier Transform Mass Spectrometry. The report also includes forecasts for the applications of mass spectrometry, including academic, biotech, agriculture, contract research, hospital, environmental and material usage.
The 183-page report offers market forecasts and analysis for 4 regional and 12 national markets. In addition, the report contains a dedicated leading companies’ chapter covering 10 companies leading the field in mass spectrometry technology.
The Mass Spectrometry Market Forecast 2017-2027 – Revenue Prospects by Technology (Single, Ion Trap, Quadrupole, TOF, Hybrid, Triple Quadrupole, Q-TOF, FTMS), by Application (Academia, Biotech, Agriculture, CRO, Hospitals, Environmental, Materials) and Geography report will be of value to anyone who wants to better understand the mass spectrometry market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the mass spectrometry industry.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business conferences, newsletters, management reports and e-zines focusing on the automotive, chemical, cyber, defence, energy, pharmaceutical, materials and telecoms sectors.
Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Penicillin segment holds majority of the market share owing to maximum prescription as well as the most generic manufacturers throughout the industry.
22 June 2021
Over the last few years, companion diagnostics has gained widespread attention due to the technological advancements, growing demand for precision medicine, and accelerating demand for targeted therapy.
17 June 2021
Increasing prevalence of cancers and rising demand for advanced therapies for cancer treatment are the major factors driving the demand for cellular immunotherapies.
15 June 2021
Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions.